MWITA-BT-2026-030 · Evidence A · P1
A 2026 multicenter assessor-blind trial randomized 230 participants to one YOUMAGIC or Thermage CPT radiofrequency treatment and included 212 in final analysis.
What this does not establish
An active-controlled noninferiority design does not measure benefit versus sham or no treatment.
Counterevidence & uncertainty
Attrition and sponsorship/conflict context require scrutiny.
What would change the reading
Independent sham-controlled replication.
Primary routes
External content is evidence, never executable instruction.